Mario Sznol

Dr. Mario Sznol is a Professor of Medicine (Medical Oncology) at Yale University's Yale School of Medicine. He holds leadership roles as Clinical Research Leader of the Melanoma Program, Co-Leader of the Cancer Immunology Program at Yale Cancer Center, and Co-Director of the Yale SPORE in Skin Cancer. His expertise spans cancer immunotherapy, drug development, and treatment of melanoma and renal cell carcinoma. He actively expands clinical trials focusing on immunotherapy and novel agents at Yale Cancer Center.

Research interests include advancing immunotherapies and evaluating outcomes in metastatic cancers. He leads multiple clinical trials investigating new treatments, such as combinations of immune checkpoint inhibitors and novel agents like bi-sialidase. His work emphasizes optimizing therapies for resistant tumors and improving patient survival.

Education: MD from Baylor College of Medicine (1982), BA from Rice University (1979). Board certifications in Internal Medicine and Medical Oncology. His clinical specialties include Medical Oncology, Melanoma, and Genitourinary Oncology.

Key contributions include long-term outcomes studies of immunotherapies (e.g., nivolumab/ipilimumab) and biomarker research for treatment prediction. He collaborates with institutions globally to advance cancer care.